Latest news
Drug Discovery & Development
CARBOGEN AMCIS Shanghai site achieves successful outcome in unannounced NMPA GMP inspection
CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and active pharmaceutical ingredient (API) manufacturing company, today announces its Shanghai facility has successfully completed an unannounced...
Funding & Finance
Evotec SE successfully places €116.1 million convertible bonds
Evotec SE has placed senior unsecured convertible bonds due 2033, convertible into new and/or existing no-par value ordinary bearer shares of the company, in...
Clinical Trials Insights
Calla Lily doses first patients in clinical trial for intravaginal drug delivery platform for threatened miscarriage
Calla Lily Clinical Care, a women’s health-focused medical technology company, has announced dosing of the first patients in the ‘freedom’ clinical trial.
The study, funded...
Pharma in Healthcare
Marty Makary resigns as chief of the Food and Drug Administration
Marty Makary, US Food and Drug Administration (FDA) commissioner, is leaving his post, US president Donald Trump said yesterday Tuesday 12 May 2026.
Mr Trump...
Pharma in Healthcare
Global nasal sprays market to reach US$ 29.7 billion by 2036, driven by rising allergy cases and non-oral drug demand
According to the latest market analysis by Future Market Insights, the global nasal sprays market is poised for consistent expansion, supported by rising incidence of allergic rhinitis,...
Pharma Packaging and Logistics
Alcami to acquire contract packaging organisation Tjoapack
Alcami Corporation, a leading US-based contract development and manufacturing organisation (CDMO), has entered into a definitive agreement to acquire Tjoapack, a leading global contract...
Clinical Trials Insights
Inhibrx provides clinical update on ozekibart in late line colorectal cancer
Inhibrx Biosciences, a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates, has released updated interim data from its phase 1/2 study evaluating...
Pharma Lab products
BioLife Solutions wins Interphex 2026 biotech innovation award for CellSeal CryoCase
BioLife Solutions, a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, has received the Interphex...
Drug Discovery & Development
US$ 8.5 million investment in malaria and other R&D projects planned among pharma giants
The global health innovative technology (GHIT) fund has announced a total investment of approximately JPY 1.37 billion (US$ 8.5 million) in five R&D projects...
Clinical Trials Insights
Positive phase 1 data for RAG-17 in amyotrophic lateral sclerosis patients with mutations in the superoxide dismutase 1 gene
Ractigen Therapeutics, a clinical-stage biopharmaceutical company focused on developing next-generation RNA-based medicines, has announced positive preliminary data from the single ascending dose (SAD) phase...
Clinical Trials Insights
New non-compromise early-phase progression accelerator launched
CARBOGEN AMCIS introduces Sprint for early-phase development, a new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour.
Sprint has been designed to...
Events and Conferences
Interphex Week Tokyo 2026 organises show floor around manufacturing, packaging, inspection and digital production technologies
Interphex Week Tokyo 2026 will take place from 20-22 May at Makuhari Messe, bringing together six specialised exhibitions and a concurrent regenerative medicine expo...
Pharma Lab products
Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell thermal cyclers
Bio-Rad Laboratories has launched the PTC Harmony Thermal Cycler line, designed to offer broader access to optimised workflows for PCR applications such as sequencing,...
Funding & Finance
Evotec announces chief financial officer transition
Evotec SE has announced that chief financial officer (CFO) Paul Hitchin will step down on 30 April 2026 for personal reasons unrelated to the...
Pharma Packaging and Logistics
PCI Pharma Services announces US$1 billion expansion of US sterile fill-finish and drug-device delivery combination capabilities
PCI Pharma Services, a world-leading integrated global contract development and manufacturing organisation (CDMO) focused on innovative biologic and small molecule therapies, has announced a...
Funding & Finance
PlaqueTec closes $5 million financing
PlaqueTec, a medtech company pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease (CVD), has raised $5 million. The oversubscribed financing round was...
- Advertisement -
- Advertisement -
- Advertisement -
MOST POPULAR POSTS
© 2026 Pharma Press Publishing.